Tafamidis meglumine is an organoammonium salt composed of tafamidis and 1-deoxy-1-(methylamino)-D-glucitol. It is used as a pharmaceutical raw material in the production of medications for the amelioration of transthyretin-related hereditary amyloidosis.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 951395-08-7
Meglumine diatrizoate
diagnostic contrast medium
N-Methyl-D-glucamine Hydrochloride
pharmaceutical intermediate
Meglumine
active pharmaceutical ingredient
6-[(3-Adamantyl-4-methoxyphenyl)]-2-naphthoic Acid Ethyl Ester
Impurity reference standard for adapalene
아토바쿠온
active pharmaceutical ingredient
Alcaftadine N-Oxide
Pharmaceutical impurity reference standard
Despentanoyl butanoyl valsartan
valsartan impurity reference standard
2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
DQJDBUPLRMRBAB-WZTVWXICSA-N
CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl